Core Insights - The product "ZUCCARI Double Anti-Birch Juice" has gained popularity on e-commerce platforms, marketed as an Italian import with anti-inflammatory benefits, and is priced at approximately 300 yuan per bottle [1][2] - The product's sales figures indicate significant consumer interest, with over 300 million yuan in total sales and nearly 11,000 units sold [2] - The parent company, Qingmu Technology, has successfully incubated the ZUCCARI brand, which has a gross margin of nearly 80%, significantly higher than other business segments [1][6] Sales Performance - The price for five bottles of "Double Anti-Birch Juice" is 1499 yuan, averaging about 300 yuan per bottle, while another product, "888 Metabolism Drink," is priced at 649 yuan per bottle [2] - The "Double Anti-Birch Juice" has sold nearly 11,000 units, contributing to over 300 million yuan in total sales across all platforms [2] Product Claims and Consumer Feedback - The product claims to improve skin texture and brightness, with reported increases of 30% and 34% respectively after 15 days of use, based on clinical trials [2] - Consumer feedback has been mixed, with some expressing skepticism about the product's effectiveness and questioning the high price [2][3] Regulatory Concerns - There are complaints regarding the lack of proper labeling in Chinese on the product, which is a requirement for imported food products in China [4] - The absence of compliant labeling raises questions about the product's legality and adherence to Chinese food safety standards [4] Company Background - Qingmu Technology, which launched the ZUCCARI brand in China in the second half of 2023, focuses on brand retail solutions and has seen significant growth in its brand incubation and management business [5] - The company reported a revenue of approximately 1.153 billion yuan for 2024, a year-on-year increase of 19.2%, with a notable growth of 126.51% in its brand incubation and management segment [5][6]

编号：2025-008 证券代码：002127 证券简称：南极电商 南极电商股份有限公司投资者关系活动记录表 | 投资者关系活 | □ 特定对象调研 √ 分析师会议 | | --- | --- | | 动类别 | □ 媒体采访 □ 业绩说明会 | | | 路演活动 □ 新闻发布会 □ | | | □ 现场参观 | | | □ 其他 | | 参与单位名称 | 中信建投证券、招商证券、华泰证券、长江证券、申万宏源证 | | 及人员姓名 | 券、广发证券、天风证券、浙商证券、国海证券、东吴证券、 | | | 德邦证券、国盛证券、华西证券、西南证券、博时基金、嘉实 | | | 基金、广发基金、金鹰基金、申万菱信、华泰资管、浦银安盛、 | | | 中银基金、博道基金、信泰人寿、Dymon Asia Capital (HK) | | | Limited、广汇缘资管、同泰基金、银华基金、建信理财、百 | | | 年保险资管、上海水璞、同犇投资、彝川资本、湖南源乘、兴 | | | 银基金、新华基金、民生加银、长安基金、厦门坤易、万家基 | | | 金、浙商资管、清和泉资本、鹏扬基金、上海川流、中泰资管、 | | | 进门财经 ...